Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future 

KRAS-mutant NSCLC treatment advances on the horizon

Date

22 Nov 2020

Session

Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future 

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Byoung Cho

Authors

B.C. Cho

Author affiliations

  • Yonsei Cancer Center, Yonsei University College of Medicine, Seoul/KR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Byoung Cho

Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future 

Resources:

Webcast

Closing

Presenter: Byoung Cho

Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future 

Resources:

Webcast

Live Q&A

Presenter: Hiroshi Tanaka

Session: Boehringer Ingelheim - Treatment Considerations for Advanced NSCLC: Now and in the Future 

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.